These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4968419)

  • 1. [Concentration of ethionamide and cycloserine in the blood of the patients with pulmonary tuberculosis].
    Ivanova ES
    Antibiotiki; 1967 Aug; 12(8):727-32. PubMed ID: 4968419
    [No Abstract]   [Full Text] [Related]  

  • 2. [Concentration of ethionamide and prothionamide in the blood of patients with pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Vrach Delo; 1973 Nov; 11():97-100. PubMed ID: 4206857
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
    Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
    Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of specific blood activity in patients with fibrous-cavernous pulmonary tuberculosis during administration of different combinations of antibacterial preparations].
    Mkrtchian SV; Utkin VV; Egorkina ND
    Antibiotiki; 1970 Oct; 15(10):955-7. PubMed ID: 5487860
    [No Abstract]   [Full Text] [Related]  

  • 5. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
    Ramakrishnan CV; Parthasarathy R; Sambamoorthy S; Somasundaram PR; Subbammal S
    Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010
    [No Abstract]   [Full Text] [Related]  

  • 6. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
    Zunić D
    Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR
    Bull Int Union Tuberc; 1968 Dec; 41():175-7. PubMed ID: 4885379
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the combination therapy of capreomycin. Ethionamide. Cycloserine with that of kanamycin. Ethionamide. Cycloserin in the retreatment of pulmonary tuberculosis.
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):1-13. PubMed ID: 4990959
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR; Lind A; Rist N
    Bull Int Union Tuberc; 1969 Aug; 42():7-57. PubMed ID: 5004884
    [No Abstract]   [Full Text] [Related]  

  • 10. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis].
    Srednicka-Zajac D; Mysakowska H; Szarewicz-Adamczyk W; Litwin B
    Ann Univ Mariae Curie Sklodowska Med; 1967; 22():71-8. PubMed ID: 4308440
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
    [No Abstract]   [Full Text] [Related]  

  • 12. Preclinical Development of Inhalable d-Cycloserine and Ethionamide To Overcome Pharmacokinetic Interaction and Enhance Efficacy against
    Ranjan R; Srivastava A; Bharti R; Roy T; Verma S; Ray L; Misra A
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of concentration of ethionamide and prothionamide in the blood of patients with pulmonary tuberculosis by polarographic method].
    Tikhonov VA; Grigaliunas AP; Guzeeva SA
    Probl Tuberk; 1976 May; (5):75-8. PubMed ID: 951413
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood level of ethionamide and prothionamide in patients with pulmonary tuberculosis].
    Tikhonov VA; Kanevskaia SS
    Probl Tuberk; 1971; 49(8):58-60. PubMed ID: 5152635
    [No Abstract]   [Full Text] [Related]  

  • 15. [A scheme of triple reserve drugs in the treatment of resistant forms of pulmonary tuberculosis].
    Rizzo A; Magalhães M; Moura N
    Hospital (Rio J); 1966 Sep; 70(3):767-83. PubMed ID: 5300283
    [No Abstract]   [Full Text] [Related]  

  • 16. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Administration of reserve antitubercular drugs in a single daily dose].
    Bek E; Bukalska Z; Zachara A
    Gruzlica; 1968; 37(1):43-7. PubMed ID: 5720037
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of two regimens, KM-TH-CS and KM-TH-EB, in retreatment cases of pulmonary tuberculosis].
    Aoyagi T; Fukuhara Y; Hondo G; Matsumiya T; Murata A
    Kekkaku; 1970 Jan; 45(1):27-36. PubMed ID: 5416951
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pyrazinamide, cycloserine and ethionamide in the complex treatment of pulmonary tuberculosis].
    Aspevik E
    Tidsskr Nor Laegeforen; 1967 Mar; 87(6):548-54. PubMed ID: 6047184
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.